This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Andrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group...
Earnings season can be a great time to validate one’s investment thesis, especially when it comes pharmaceutical companies that have always have something interesting...